CTS Tampa has implemented the Ortho Vitros Anti-SARS-CoV-2 Total test which qualitatively detects antibody (including IgG and IgM) to SARS-CoV-2 S protein on April 20, 2020. Additionally, Vitalant Research Institute is offering the SARS-CoV-2 Reporter Viral Particle Neutralization (RVPN) test.
The situation is rapidly developing and we know you likely have many questions, but you can find all the current information here: Communications
We will be sending updates as we get more details to share with you!
In response to the FDA guidance document for Babesia, CTS will implement the licensed Grifols ...
The revised CTS algorithm associated with the Ortho platform is now available for review. Clie...
The CTS 2020 Annual Laboratory Survey is on its way to your email box. We would appreciate you takin...
Creative Testing Solutions, the largest nonprofit blood testing organization in the U.S., today anno...
We received an updated WNV package insert; please note the manufacturer and license number has been ...
CTS was recently notified that one of the tubes listed in the Sample Acceptability document...